Mapping m 6 A Sites on HIV-1 RNA Using Oligonucleotide LC-MS/MS.
Alice BaekAsif RayhanGa-Eun LeeSarah GolcondaHannah YuShihyoung KimPatrick A LimbachBalasubrahmanyam AddepalliSanggu KimPublished in: Methods and protocols (2024)
The biological significance of chemical modifications to the ribonucleic acid (RNA) of human immunodeficiency virus type-1 (HIV-1) has been recognized. However, our understanding of the site-specific and context-dependent roles of these chemical modifications remains limited, primarily due to the absence of nucleotide-resolution mapping of modification sites. In this study, we present a method for achieving nucleotide-resolution mapping of chemical modification sites on HIV-1 RNA using liquid chromatography and tandem mass spectrometry (LC-MS/MS). LC-MS/MS, a powerful tool capable of directly analyzing native RNAs, has proven effective for mapping RNA modifications in small RNA molecules, including ribosomal RNA and transfer RNA. However, longer RNAs have posed challenges, such as the 9 Kb HIV-1 virion RNA, due to the complexity of and ambiguity in mass differences among RNase T1-cleaved RNA fragments in LC-MS/MS data. Here, we introduce a new target RNA enrichment method to isolate small local RNA fragments of HIV-1 RNA that potentially harbor site-specific N6-methyladenosine (m 6 A) modifications. In our initial trial, we used target-specific DNA probes only and encountered insufficient RNA fragmentation due to inefficient S1 digestion near the target site. Recognizing that inefficient S1 digestion by HIV-1 RNA is likely due to the formation of secondary structures in proximity to the target site, we designed multiple DNA probes annealing to various sites of HIV-1 RNA to better control the structures of RNA substrates for S1 digestion. The use of these non-target DNA probes significantly improved the isolation of more homogeneous target RNA fragments of approximately 50 bases in length. Oligonucleotide LC-MS/MS analysis of these isolated target RNA fragments successfully separated and detected both m 6 A-methylated and non-methylated oligomers at the two m 6 A-predicted sites. The principle of this new target enrichment strategy holds promise and should be broadly applicable to the analysis of any lengthy RNA that was previously deemed infeasible for investigation using oligonucleotide LC-MS/MS.
Keyphrases
- human immunodeficiency virus
- nucleic acid
- antiretroviral therapy
- hepatitis c virus
- hiv infected
- single molecule
- liquid chromatography
- randomized controlled trial
- clinical trial
- small molecule
- mass spectrometry
- photodynamic therapy
- study protocol
- circulating tumor
- fluorescence imaging
- high performance liquid chromatography
- phase iii
- high resolution mass spectrometry
- data analysis